Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
No responses to oral etoposide in 15 patients with recurrent brain tumors.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
No responses to oral etoposide in 15 patients with recurrent brain tumors.
No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
View in:
PubMed
subject areas
Administration, Oral
Adolescent
Adult
Antineoplastic Agents, Phytogenic
Brain Neoplasms
Child
Child, Preschool
Etoposide
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Treatment Outcome
authors with profiles
Kenneth S. Cohen